<VariationArchive RecordType="classified" VariationID="514" VariationName="NM_000037.4(ANK1):c.520_539del (p.Leu174fs)" VariationType="Deletion" Accession="VCV000000514" Version="1" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2023-03-26" DateCreated="2017-12-15" MostRecentSubmission="2017-12-15">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="15553" VariationID="514">
      <GeneList>
        <Gene Symbol="ANK1" FullName="ankyrin 1" GeneID="286" HGNC_ID="HGNC:492" Source="submitted" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>8p11.21</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="8" Accession="NC_000008.11" start="41653225" stop="41896741" display_start="41653225" display_stop="41896741" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="8" Accession="NC_000008.10" start="41510743" stop="41754279" display_start="41510743" display_stop="41754279" Strand="-" />
          </Location>
          <OMIM>612641</OMIM>
        </Gene>
        <Gene Symbol="LOC124153154" FullName="Sharpr-MPRA regulatory region 1462" GeneID="124153154" Source="calculated" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>8p11.21</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="8" Accession="NC_000008.11" start="41725651" stop="41726294" display_start="41725651" display_stop="41726294" Strand="+" />
          </Location>
        </Gene>
      </GeneList>
      <Name>NM_000037.4(ANK1):c.520_539del (p.Leu174fs)</Name>
      <CanonicalSPDI>NC_000008.11:41725833:GCGATGTGCAGGGCCGGGAGGCG:GCG</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>8p11.21</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="8" Accession="NC_000008.11" start="41725834" stop="41725853" display_start="41725834" display_stop="41725853" variantLength="20" positionVCF="41725833" referenceAlleleVCF="CGCGATGTGCAGGGCCGGGAG" alternateAlleleVCF="C" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="8" Accession="NC_000008.10" start="41583352" stop="41583371" display_start="41583352" display_stop="41583371" variantLength="20" positionVCF="41583351" referenceAlleleVCF="CGCGATGTGCAGGGCCGGGAG" alternateAlleleVCF="C" />
      </Location>
      <ProteinChange>L207fs</ProteinChange>
      <ProteinChange>L174fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000008.10" sequenceAccession="NC_000008" sequenceVersion="10" change="g.41583355_41583374del" Assembly="GRCh37">
            <Expression>NC_000008.10:g.41583355_41583374del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000008.11" sequenceAccession="NC_000008" sequenceVersion="11" change="g.41725837_41725856del" Assembly="GRCh38">
            <Expression>NC_000008.11:g.41725837_41725856del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_012820.2" sequenceAccession="NG_012820" sequenceVersion="2" change="g.175910_175929del">
            <Expression>NG_012820.2:g.175910_175929del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000037.4" sequenceAccession="NM_000037" sequenceVersion="4" change="c.520_539del" MANESelect="true">
            <Expression>NM_000037.4:c.520_539del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000028.3" sequenceAccession="NP_000028" sequenceVersion="3" change="p.Leu174fs">
            <Expression>NP_000028.3:p.Leu174fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001142446.2" sequenceAccession="NM_001142446" sequenceVersion="2" change="c.619_638del">
            <Expression>NM_001142446.2:c.619_638del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001135918.1" sequenceAccession="NP_001135918" sequenceVersion="1" change="p.Leu207fs">
            <Expression>NP_001135918.1:p.Leu207fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_020475.3" sequenceAccession="NM_020475" sequenceVersion="3" change="c.520_539del">
            <Expression>NM_020475.3:c.520_539del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_065208.2" sequenceAccession="NP_065208" sequenceVersion="2" change="p.Leu174fs">
            <Expression>NP_065208.2:p.Leu174fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_020476.3" sequenceAccession="NM_020476" sequenceVersion="3" change="c.520_539del">
            <Expression>NM_020476.3:c.520_539del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_065209.2" sequenceAccession="NP_065209" sequenceVersion="2" change="p.Leu174fs">
            <Expression>NP_065209.2:p.Leu174fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_020477.3" sequenceAccession="NM_020477" sequenceVersion="3" change="c.520_539del">
            <Expression>NM_020477.3:c.520_539del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_065210.2" sequenceAccession="NP_065210" sequenceVersion="2" change="p.Leu174fs">
            <Expression>NP_065210.2:p.Leu174fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA212748" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="612641.0008" DB="OMIM" />
        <XRef Type="rs" ID="786205244" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000037.4(ANK1):c.520_539del (p.Leu174fs) AND Spherocytosis, type 1, autosomal recessive" Accession="RCV000000543" Version="5">
        <ClassifiedConditionList TraitSetID="140">
          <ClassifiedCondition DB="MedGen" ID="C4017275">Spherocytosis, type 1, autosomal recessive</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2005-09-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2005-09-01" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2017-12-15" MostRecentSubmission="2017-12-15">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">16037067</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">8640229</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="140" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="9645" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Spherocytosis, type 1, autosomal recessive</ElementValue>
              </Name>
              <XRef ID="C4017275" DB="MedGen" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="20692" SubmissionDate="2017-12-11" DateLastUpdated="2017-12-15" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="612641.0008_SPHEROCYTOSIS, TYPE 1, AUTOSOMAL RECESSIVE" title="ANK1, 20-BP DEL, NT604_SPHEROCYTOSIS, TYPE 1, AUTOSOMAL RECESSIVE" />
        <ClinVarAccession Accession="SCV000020692" DateUpdated="2017-12-15" DateCreated="2013-04-04" Type="SCV" Version="4" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2005-09-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In a female German patient with moderate spherocytosis (SPH1; 182900), Eber et al. (1996) identified a 20-bp deletion in exon 6 of the ANK1 gene, resulting in frameshift and premature termination. Subsequently, following reexamination of the patient, Gallagher et al. (2005) identified compound heterozygosity for the 20-bp deletion and a 2-bp deletion (-72delTG; 612641.0009) in the ANK1 promoter adjacent to a transcription initiation site. Both parents had normal hematocrits, increased reticulocyte counts, and abnormal erythrocyte incubated osmotic fragility, typical for the diagnosis of HS with compensated hemolysis. The mother carried the 20-bp deletion. The father was presumed to carry the 2-bp deletion but was deceased, and there was no genetic material available for testing. In vitro analysis of the mutant promoter showed decreased levels of ANK1 expression, altered transcription initiation site utilization and defective binding of TATA-binding protein (TBP; 600075) and TFIID (TAF1; 313650) complex formation. In a transgenic mouse model, the mutant ankyrin promoter led to abnormalities in ANK1 expression, including decreased expression of a reporter gene and altered transcription initiation site utilization. The authors concluded that the promoter mutation altered ANK1 gene transcription and contributes to the HS phenotype by decreasing ankyrin gene synthesis via disruption of TFIID complex interactions with the ankyrin core promoter. Gallagher et al. (2005) proposed that in promoters that lack conserved cis elements, the TFIID complex may direct preinitiation complex formation at specific sites in core promoter DNA.</Attribute>
              <Citation>
                <ID Source="PubMed">8640229</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">16037067</ID>
              </Citation>
              <XRef DB="OMIM" ID="182900" Type="MIM" />
              <XRef DB="OMIM" ID="600075" Type="MIM" />
              <XRef DB="OMIM" ID="313650" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ANK1" />
          </GeneList>
          <Name>ANK1, 20-BP DEL, NT604</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">20-BP DEL, NT604</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="612641.0008" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">SPHEROCYTOSIS, TYPE 1, AUTOSOMAL RECESSIVE</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="20692" TraitType="Disease" MappingType="Name" MappingValue="SPHEROCYTOSIS, TYPE 1, AUTOSOMAL RECESSIVE" MappingRef="Preferred">
        <MedGen CUI="C4017275" Name="Spherocytosis, type 1, autosomal recessive" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

